Documentos de Académico
Documentos de Profesional
Documentos de Cultura
MEDICAL SCHOOL
(Training manuals)
Moscow
2001
SKIN CANCER
Skin cancer accounts for 90% of all malignant tumors of the skin.
In the basal layer of the epidermis are cells which produce the dark coloured pigment called melanin.
Mature cells that produce melanin are called melanocytes. Immature cells - melanoblasts. From
melanoblasts arise pigmented tumors - melanoma.
Skin cancer is one of the most common tumors and occurs in 20-40 patients per 100000 population. The
incidence increases directly proportional to age of the patients. The most frequently skin cancers occur in
people older than 70 years. Women and men are affected equally. Skin cancer is more common among
residents of southern regions, people with fair skin, working outdoors.
b) Optional pre-cancerous (chronic dermatitis, wounds and ulcers, cutaneous horn, senile keratosis,
keratoacanthoma)
Keratoacanthoma - benign tumor of epidermal hair follicles. Has the form of spherical knot with crater-like
hollow in the center.
1. Basal cell carcinoma arising from cells of the basal layer of epidermis. Upto 70-75% of all skin cancers.
Localized mainly on the face. Has a slow local growth. Virtually not metastasizing
2. Squamous cell carcinoma - usually occurs against a background of precancerous conditions. Has a
rapid infiltrative growth and has potential for regional metastasis. Distant metastases are rare (lung, bone).
Localization
Skin cancer most often occurs on exposed parts of the body-70%
On body tumor occurs in 5-10% of patients
On the extremities - 5-10%
Classification TNM:
T1 - Tumor upto 2 cm
T2 - 2 to 5 cm with a slight infiltration of the dermis
T3 - more than 5 cm or tumor with deep infiltration of the dermis
T4 - tumor infiltrating other structures (cartilage, muscle, bone).
Stages:
Stage I - T1N0M0
Stage II - T2-3N0M0
Stage III-T4N0M0, T1-3N1M0
Stage IV - T1-4N0-1M1
1. Surface form - the most common variant. In the form of a small nodule yellowish or grayish in color.
Often at the center of the plaque retraction and erosion is seen. Most frequently encountered in the basal
cell carcinoma.
2. Infiltrative form - deep ulceration with a bumpy, uneven bottom and edge. Most often, this form
corresponds to squamous cancer.
3. Papillary form rarely seen as a solid nodule on a broad base.Nodular surface often resembles a
cauliflower ,mostly seen with squamous cell carcinoma.
Morphologic Diagnosis:
Melanoma is about 1% of all malignant diseases. Occurs in 2-4 persons per 100000 population.
In women, melanoma occurs most often by 3 times.
Most often arises in the age group 30-39 years.
Most often found in southern countries.
Localization of melanoma:
Locally growth of melanoma occurs in three ways: over the skin, on the surface and depth. The deeper the
invasion into the skin worse the prognosis.
Metastasis:
1. Lymphogenic metastases in regional lymph nodes is occurs early and vigorously.
2. Metastases in the skin as "satellite" or diffuse infiltration of the skin.
3. Hematogenous most often in the lungs, liver, brain, skeleton.
Signs of melanoma:
1. Dark color
2. Shiny smooth surface
3. Disappearance of the skin pattern
4. Tendency to ulceration and decay (in the later stages)
Morphological verification:
Because of the risk of dissemination ,biopsy is not done. Sample can be taken for cytological examination
from the eroded surface.
TREATMENT OF MELANOMA
Surgical treatment:
Wide excision with restrain from edge of not less than 5 cm (on the face 3 cm). Flap should be removed
deeply. Skin is removed along with subcutaneous tissue and fascia.
Often, after removal of melanoma, plastic surgery is performed. Usually the plastic is taken from any free
skin graft. If the location of the tumor is in the fingers or toes, disarticulation is done.
Lymphadenectomy is performed only with a confirmed metastasis to regional lymph nodes. (Prophylactic
lymphadenectomy does not improve the results.)
Immunotherapy - BCG vaccine - used in treatment of relapse and cutaneous metastases. The vaccine is
injected into the tumor sites.
Results of treatment:
In Ist and IInd degree of invasion 5 year survival rate reaches 50%